We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBOC:NASDAQInternational Bancshares Corporation Analysis

Data as of 2026-04-09 - not real-time

$69.99

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

International Bancshares trades well below its discounted cash‑flow estimate, offering a material upside potential while its price‑to‑earnings multiple sits comfortably under the industry average. Operating margins are robust at roughly 65% and the company generates solid operating cash flow, supporting a 2% dividend yield with a modest payout ratio. The technical picture shows a bullish MACD histogram and an RSI in the low‑60s, suggesting lingering buying pressure, yet daily volume is on a downtrend and the price hovers near the identified resistance level. With a beta under 1 and 30‑day volatility around the low‑20% range, the stock exhibits lower market sensitivity than many peers. The balance sheet is strong, featuring ample cash relative to debt and a healthy book‑value per share, which underpins dividend sustainability. However, analyst coverage is thin, and the neutral trend direction combined with decreasing volume adds a short‑term caution flag. Overall, the fundamentals and valuation gap point to a compelling case for investors seeking value‑oriented exposure in the regional banking sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near resistance with decreasing volume
  • bullish MACD but neutral trend direction
  • strong cash flow supporting dividend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant upside to DCF fair value
  • low beta and solid balance sheet
  • attractive valuation relative to industry peers

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • sustainable dividend yield and low payout ratio
  • consistent operating profitability
  • regional market focus with limited geographic concentration

Key Metrics & Analysis

Financial Health

Revenue Growth2.60%
Profit Margin49.85%
P/E Ratio10.6
ROE13.63%
ROA2.55%
P/B Ratio1.3
Op. Cash Flow$491.1M
Industry P/E17.2

Technical Analysis

TrendNeutral
RSI61.5
Support$65.52
Resistance$70.77
MA 20$67.70
MA 50$69.28
MA 200$68.88
MACDBullish
VolumeDecreasing
Fear & Greed Index83.84

Valuation

Fair Value$80.62
Target Price$87.00
Upside/Downside24.30%
GradeUndervalued
TypeValue
Dividend Yield2.03%

Risk Assessment

Beta0.81
Volatility22.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.